The Interface Blog is the best place to find detailed perspectives on autoimmune hepatitis. We publish the most up-to-date news, educational pieces, and stories about patients just like you.
By the Autoimmune Hepatitis Association As we have shared this past year, very rare cases of autoimmune-like liver injury after COVID-19 vaccine have been reported in...
By the Autoimmune Hepatitis Association The Omicron variant of SARS-CoV-2 is spreading quickly across the globe. Scientists are still sorting out its impact, but we...
By The Autoimmune Hepatitis Association On the first day of winter, we share more about a unique phenomenon observed in some autoimmune diseases: how the change of...
By Craig Lammert, M.D., AIHA Executive Director One of the most common questions our members ask is “how common is AIH?" Unfortunately, it’s a challenging question, and...
Just as the COVID-19 pandemic was beginning in the United States in early 2020, Chicago-area resident Dave Richardson started to feel sluggish and tired all the time....
By the Autoimmune Hepatitis Association New recommendations for booster vaccines have been issued in the US for those who received the Moderna and Johnson & Johnson...
By Craig Lammert, M.D., AIHA Executive Director Currently, the most important treatment goal for autoimmune hepatitis (AIH) is normal liver tests (AST and ALT) and IgG...
Autoimmune Hepatitis Association (AIHA) Founding Member Lisa Devereaux has been a longtime supporter of the AIHA, from making monetary donations to volunteering...
By the Autoimmune Hepatitis Association Advisers to the Centers for Disease Control and Prevention (CDC) voted unanimously in favor of a third dose of Pfizer (age 12 or...
By Erin AndersonAIHA Director of Programs and Advancement If having autoimmune disease were a competition, Lee Gipson (below left) jokes that she would take home the...
By the Autoimmune Hepatitis Association Researchers have published the first report of using a third dose of vaccine to 30 organ transplant patients with suboptimal...
By the Autoimmune Hepatitis Association In May, a follow-up study from researchers at John Hopkins showed how immunosuppressed patients respond after the second dose of...
By the Autoimmune Hepatitis Association The full impact of SARS-CoV-2 infection (the virus causing COVID-19) on autoimmune hepatitis (AIH) patients is still unknown....
New research is raising concerns about how well COVID-19 vaccines work for patients on immunosuppressants. AIHA Executive Director Craig Lammert, M.D., puts a new study...
The Johnson & Johnson vaccine is now available in some areas in the US, and many patients have questions about whether it's safe. We have answers! AIHA Executive...